For deep-tech investors
Confirm scale-up readiness
in deep-tech deals
EvidenceStack helps VC, CVC, angel syndicates, and venture teams assess whether regulated, hardware-heavy deep-tech companies can scale from prototype maturity to scalable execution.
For Seed to Series A deals in aerospace, defence, dual-use, energy hardware, clean-tech, electronics, industrial automation, and advanced manufacturing.
View what EvidenceStack checks
Use it when
Use EvidenceStack when the deal looks strong, but scale-up readiness is still unclear.
EvidenceStack is designed for investment moments where a prototype, demo, or technical claim needs to be translated into decision-ready evidence.
The maturity story depends on founder claims
You need to understand what has actually been tested, under which conditions, and what remains assumed.
TRL is stated, but the evidence is unclear
TRL is useful, but insufficient when integration, certification, manufacturing, and execution risks remain open.
Integration risk could hide the real problem
The technology may work in isolation while the system, interfaces, suppliers, or operating constraints are not yet mature.
IC, follow-on, or tranche decisions need more confidence
Turn technical uncertainty into a structured view of risks, evidence gaps, and next de-risking milestones.
The fund lacks operator depth in this domain
Use an external aerospace and deep-tech operator lens to challenge the maturity case before scale-up assumptions harden.
The gut feeling is good, but we lack evidence
Go beyond the deck, the claims, and the founder's passion. Check the evidence across the critical scale-up pillars.
Not sure if a deal needs deeper diligence?
Run a free scale-up risk screen to identify whether the main concern is technology maturity, integration, manufacturing, certification, IP, or execution readiness.
The free screen is a first signal. The triage call and 5-day review are for investors working with live or near-live deals.
What EvidenceStack checks
What EvidenceStack checks
We look beyond whether the technology works. We assess whether the company can integrate, industrialize, certify, defend, and execute the path to scale.
Technology maturity
Is the core technology validated under relevant conditions, or only demonstrated in a narrow prototype context?
Integration maturity
Are interfaces, dependencies, system constraints, and verification logic clear enough to support scale-up?
Manufacturing readiness
Can the team move from prototype builds to repeatable production without major cost, quality, supplier, or process surprises?
Certification and regulatory path
Are the applicable standards, evidence needs, and approval path understood early enough to avoid late-stage delays?
IP and defensibility
Is the technical position protectable, ownable, and sufficiently clear from an investor risk perspective?
Execution capability
Does the team have the operating model, competences, roadmap, and governance needed to de-risk scale-up?
Conversion path
Start narrow, and go deeper only when the deal needs it
Free scale-up risk screen
A quick signal to identify whether the main concern is technology, integration, manufacturing, certification, IP, or execution readiness.
15-min deal triage call
A short call to confirm whether the deal needs a fast external operator view, a deeper review, or no extra work yet.
5-business-day Scale-Up Risk Triage
A fixed-scope review for live or near-live deals where scale-up readiness is still unclear.
Full EvidenceStack Assessment
A deeper diligence engagement for live deals, follow-on decisions, or portfolio companies that need a broader readiness view.
Start with a Scale-Up Risk Triage
Start with a Scale-Up Risk Triage
A 5-business-day, fixed-scope review for investors who need a first external view before deeper diligence.
Use the free screen for a first signal. Use the Scale-Up Risk Triage when you have a live or near-live deal and need an external operator view before IC, follow-on, or tranche decisions.
Designed for live or near-live deals where the main question is not whether the pitch is attractive, but whether the scale-up story is credible.
Use it before IC, post-term sheet, before follow-on, or when defining tranche-readiness milestones.
What you get
- Review of the deck, maturity claims, and available evidence
- Identification of 3 to 5 critical scale-up risks
- Evidence gap map
- Investor diligence questions
- Recommendation: no issue, watch item, or deeper review needed
EvidenceStack Assessment
EvidenceStack Assessment
For live deals, follow-on decisions, or portfolio companies where a deeper readiness view is needed.
Use the full assessment when the triage shows the deal needs a broader evidence review, more detailed risk framing, or a deeper view of tranche-readiness.
IC-ready readiness report
Evidence stack
Risk register
Maturity gap map
Milestone and tranche-readiness view
Recommended de-risking roadmap
Who this is for
Best fit
- Seed to Series A deep-tech
- VC, CVC, venture builders, family offices, and deep-tech angel syndicates
- Hardware-heavy or regulated products
- Aerospace, defence, dual-use, energy hardware, clean-tech, electronics, industrial automation, or advanced manufacturing
- Prototype exists, but evidence behind scale-up claims is incomplete
- Investor needs confidence before IC, closing, follow-on, or tranche release
Not the best fit
- Pure SaaS with low technical or integration risk
- Idea-stage companies without evidence
- Generic pitch-deck review
- Funds already running deep internal technical diligence in the specific domain
- Teams looking only for fundraising storytelling
Operator credibility
Built from aerospace and deep-tech scale-up experience
EvidenceStack is built by aerospace and deep-tech operators with 15+ years across aircraft systems, product development, digitalization, PLM, systems engineering, and scale-up execution.
Common questions
How is this different from standard technical diligence?▾
Standard technical diligence often confirms whether the current technology works. EvidenceStack tests whether the business can scale: integration, industrialization, certification, execution, defensibility, and milestone logic.
Do you only evaluate TRL?▾
No. TRL is useful but insufficient. We test the wider readiness-to-scale conditions that decide whether capital is protected or exposed.
When should we run this?▾
Most often before IC, during technical diligence, before releasing a new tranche, or before follow-on investment.
What does the output help us do?▾
It improves go or no-go clarity, tightens milestone structuring, supports valuation discipline, and improves post-investment monitoring.
How do you handle confidentiality and independence?▾
NDA is standard. Access can be read-only. The work is independent and evidence-led, designed for investor decision quality, not founder advocacy.
Bring a live or near-live deal into triage
Start with the free risk screen if you need a first signal. Book a triage call when the deal needs a faster external operator view before you commit more time or capital.
Founder team? Visit the founder page.